A Study to Assess the Effect of Intensive Uric Acid (UA) Lowering Therapy With RDEA3170, Febuxostat, Dapagliflozin on Urinary Excretion of UA

Name: A Study to Assess the Effect of Intensive Uric Acid (UA) Lowering Therapy With RDEA3170, Febuxostat, Dapagliflozin on Urinary Excretion of UA
Published: 2017
License: Public Domain

AstraZeneca · 2017

ClinicalTrials.gov · Datasets · License: Public Domain · 2017

Open Source ↗

uric-acid

asymptomatic hyperuricemia, gout, uric acid, hyperuricemia, asymptomatic gout, febuxostat, dapagliflozin, uric acid transporter 1 (urat1) inhibitor, xanthine oxidase inhibitor, sodium-glucose cotransporter 2 (sglt2) inhibitor, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Study to Assess the Effect of Intensive Uric Acid (UA) Lowering Therapy With RDEA3170, Febuxostat, Dapagliflozin on Urinary Excretion of UA

Related documents